Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (Adriamycin) in doxorubicin-resistant p388 mouse leukaemia cells

R. Ganapathi; A. Yen; D. Grabowski; H. Schmidt; R. Turinic; R. Valenzuela

doi:10.1038/bjc.1986.88

Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (Adriamycin) in doxorubicin-resistant p388 mouse leukaemia cells

R. Ganapathi, A. Yen, D. Grabowski, H. Schmidt, R. Turinic, R. Valenzuela

Pathology

Research output: Contribution to journal › Article

10 Scopus citations

Original language	English (US)
Pages (from-to)	561-566
Number of pages	6
Journal	British Journal of Cancer
Volume	53
Issue number	4
DOIs	https://doi.org/10.1038/bjc.1986.88
State	Published - Apr 1986

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1038/bjc.1986.88

Cite this

Ganapathi, R., Yen, A., Grabowski, D., Schmidt, H., Turinic, R., & Valenzuela, R. (1986). Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (Adriamycin) in doxorubicin-resistant p388 mouse leukaemia cells. British Journal of Cancer, 53(4), 561-566. https://doi.org/10.1038/bjc.1986.88

Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (Adriamycin) in doxorubicin-resistant p388 mouse leukaemia cells. / Ganapathi, R.; Yen, A.; Grabowski, D.; Schmidt, H.; Turinic, R.; Valenzuela, R.

In: British Journal of Cancer, Vol. 53, No. 4, 04.1986, p. 561-566.

Research output: Contribution to journal › Article

Ganapathi, R, Yen, A, Grabowski, D, Schmidt, H, Turinic, R & Valenzuela, R 1986, 'Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (Adriamycin) in doxorubicin-resistant p388 mouse leukaemia cells', British Journal of Cancer, vol. 53, no. 4, pp. 561-566. https://doi.org/10.1038/bjc.1986.88

Ganapathi R, Yen A, Grabowski D, Schmidt H, Turinic R, Valenzuela R. Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (Adriamycin) in doxorubicin-resistant p388 mouse leukaemia cells. British Journal of Cancer. 1986 Apr;53(4):561-566. https://doi.org/10.1038/bjc.1986.88

Ganapathi, R. ; Yen, A. ; Grabowski, D. ; Schmidt, H. ; Turinic, R. ; Valenzuela, R. / Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (Adriamycin) in doxorubicin-resistant p388 mouse leukaemia cells. In: British Journal of Cancer. 1986 ; Vol. 53, No. 4. pp. 561-566.

@article{a3c07e14154f4c88bcb1c28ed5d3df1d,

title = "Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (Adriamycin) in doxorubicin-resistant p388 mouse leukaemia cells",

author = "R. Ganapathi and A. Yen and D. Grabowski and H. Schmidt and R. Turinic and R. Valenzuela",

year = "1986",

month = apr,

doi = "10.1038/bjc.1986.88",

language = "English (US)",

volume = "53",

pages = "561--566",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (Adriamycin) in doxorubicin-resistant p388 mouse leukaemia cells

AU - Ganapathi, R.

AU - Yen, A.

AU - Grabowski, D.

AU - Schmidt, H.

AU - Turinic, R.

AU - Valenzuela, R.

PY - 1986/4

Y1 - 1986/4

UR - http://www.scopus.com/inward/record.url?scp=0022591558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022591558&partnerID=8YFLogxK

U2 - 10.1038/bjc.1986.88

DO - 10.1038/bjc.1986.88

M3 - Article

C2 - 3707847

AN - SCOPUS:0022591558

VL - 53

SP - 561

EP - 566

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 4

ER -